Zheng Weishuai, Zou Menglin, Hu Xingxing, Gao Han, Song Weiwei, Hou Qinhui, Liu Yuan, Cheng Zhenshun
Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Department of Respiratory and Critical Care Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Commun Biol. 2025 Jan 20;8(1):93. doi: 10.1038/s42003-025-07529-7.
Invasive lung myofibroblasts are the main cause of tissue remodeling in idiopathic pulmonary fibrosis (IPF). A key mechanism contributing to this important feature is aberrant crosstalk between the abnormal/injured lung epithelium and pulmonary fibroblasts. Here, we demonstrate that lungs from patients with IPF and from mice with bleomycin (BLM)-induced pulmonary fibrosis (PF) are characterized by the induction of human epididymis protein 4 (HE4) overexpression in epithelial cells. HE4 knockdown primarily in epithelial cells attenuates BLM-induced PF in mice, whereas the administration of recombinant mouse HE4 exacerbates fibrosis after BLM stimulation. Mechanistic analysis shows that HE4 and annexin II (ANXA2) specific binding enhances the profibrotic phenotype in epithelial cells, and directly promotes lung fibroblast activation, leading to aberrant epithelial-fibroblast crosstalk and the persistent myofibroblast phenotype. The HE4 and ANXA2 binding site is located after the 30th amino acid at the N terminus of the HE4 molecule. Finally, intratracheal administration of HE4 shRNA lentivirus protects mice against BLM-induced PF. These data suggest that HE4 can serve as a potential therapeutic target in the treatment of IPF.
侵袭性肺肌成纤维细胞是特发性肺纤维化(IPF)中组织重塑的主要原因。导致这一重要特征的关键机制是异常/受损的肺上皮细胞与肺成纤维细胞之间的异常串扰。在此,我们证明,IPF患者以及博来霉素(BLM)诱导的肺纤维化(PF)小鼠的肺组织,其特征在于上皮细胞中人附睾蛋白4(HE4)的表达上调。主要在上皮细胞中敲低HE4可减轻小鼠BLM诱导的PF,而给予重组小鼠HE4则会加剧BLM刺激后的纤维化。机制分析表明,HE4与膜联蛋白II(ANXA2)的特异性结合增强了上皮细胞中的促纤维化表型,并直接促进肺成纤维细胞活化,导致异常的上皮-成纤维细胞串扰和持续的肌成纤维细胞表型。HE4与ANXA2的结合位点位于HE4分子N端第30个氨基酸之后。最后,气管内给予HE4 shRNA慢病毒可保护小鼠免受BLM诱导的PF。这些数据表明,HE4可作为治疗IPF的潜在治疗靶点。